| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Catherine Verfaillie | Q615166 |
| P2093 | author name string | Stefaan W Van Gool | |
| Sandra A Jacobs | |||
| Valerie D Roobrouck | |||
| P2860 | cites work | Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium | Q82092596 |
| Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study | Q82341953 | ||
| Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study | Q82808694 | ||
| Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts | Q83074981 | ||
| Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease | Q83272771 | ||
| Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model | Q83978985 | ||
| Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study | Q84197372 | ||
| Development of a surrogate angiogenic potency assay for clinical-grade stem cell production | Q84352859 | ||
| Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report | Q84931084 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 | ||
| Human adipose tissue is a source of multipotent stem cells | Q29617385 | ||
| Pluripotency of mesenchymal stem cells derived from adult marrow | Q29617959 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
| Mesenchymal stem cells | Q29619804 | ||
| Mesenchymal stem cells as trophic mediators | Q29619806 | ||
| Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment | Q29620053 | ||
| Human mesenchymal stem cells modulate B-cell functions | Q29620705 | ||
| Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies | Q30195546 | ||
| Multipotent adult progenitor cells sustain function of ischemic limbs in mice. | Q30480928 | ||
| Isolation of Oct4-expressing extraembryonic endoderm precursor cell lines | Q33507094 | ||
| Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells | Q33658734 | ||
| Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. | Q34007524 | ||
| Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells | Q34129368 | ||
| What is a natural killer cell? | Q34468687 | ||
| Mesenchymal stem cell as salvage treatment for refractory chronic GVHD | Q34562177 | ||
| SSEA-4 identifies mesenchymal stem cells from bone marrow | Q34576375 | ||
| Neuroectodermal differentiation from mouse multipotent adult progenitor cells | Q34582250 | ||
| Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. | Q34788797 | ||
| Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells | Q34868815 | ||
| Treatment of inflammatory diseases with mesenchymal stem cells | Q34987147 | ||
| Indoleamine 2,3 dioxygenase and regulation of T cell immunity | Q36255493 | ||
| Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature | Q36591314 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. | Q36643178 | ||
| Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. | Q36808861 | ||
| Mesenchymal stem cells in hematopoietic stem cell transplantation | Q37396930 | ||
| Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation | Q73756569 | ||
| Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies | Q74505218 | ||
| Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatc | Q74674032 | ||
| Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex | Q78833880 | ||
| Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells | Q79208808 | ||
| In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells | Q79353484 | ||
| Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation | Q79657081 | ||
| Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells | Q79791862 | ||
| Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells | Q80057941 | ||
| Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells | Q80413361 | ||
| The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study | Q80471824 | ||
| Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation | Q81298136 | ||
| Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children | Q81384595 | ||
| NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation | Q81508180 | ||
| T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression | Q81704121 | ||
| HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells | Q37474210 | ||
| Stem cells in the treatment of inflammatory arthritis | Q37781919 | ||
| Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases | Q37891375 | ||
| Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells | Q39076711 | ||
| Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions | Q39571426 | ||
| Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow | Q39723073 | ||
| Origin of endothelial progenitors in human postnatal bone marrow | Q39737487 | ||
| Interactions between human mesenchymal stem cells and natural killer cells | Q40385365 | ||
| CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. | Q41332088 | ||
| Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. | Q41832951 | ||
| Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair | Q43164474 | ||
| MAPC culture conditions support the derivation of cells with nascent hypoblast features from bone marrow and blastocysts | Q43210499 | ||
| Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells | Q43254669 | ||
| Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation | Q44317237 | ||
| Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study | Q44718232 | ||
| Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation | Q44746492 | ||
| Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation | Q44786842 | ||
| Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes | Q45024308 | ||
| Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. | Q45859658 | ||
| Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. | Q45962719 | ||
| MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. | Q46034364 | ||
| Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms | Q46390299 | ||
| Mesenchymal stem cells induce apoptosis of activated T cells | Q46622786 | ||
| Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. | Q46939105 | ||
| Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment | Q47273161 | ||
| Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms | Q47945142 | ||
| Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. | Q50790713 | ||
| Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell. | Q51943608 | ||
| Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. | Q52008649 | ||
| Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. | Q53515532 | ||
| Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. | Q53652498 | ||
| Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. | Q54396842 | ||
| Human Multipotent Adult Progenitor Cells Are Nonimmunogenic and Exert Potent Immunomodulatory Effects on Alloreactive T-Cell Responses | Q56777630 | ||
| In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells | Q56777865 | ||
| Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype | Q56902900 | ||
| Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells | Q59102107 | ||
| Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells | Q61645531 | ||
| Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease | Q63197317 | ||
| Imprinted X-inactivation in extra-embryonic endoderm cell lines from mouse blastocysts | Q64147198 | ||
| Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use | Q70803151 | ||
| Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma | Q73015244 | ||
| Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy | Q73358706 | ||
| Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages | Q73438633 | ||
| Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age | Q73521753 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| cell | Q7868 | ||
| mesenchymal stem cell | Q1922379 | ||
| bone marrow cells | Q66004840 | ||
| hemic and immune systems | Q70202933 | ||
| P304 | page(s) | 32-9 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Immunology & Cell Biology | Q13731918 |
| P1476 | title | Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells | |
| P478 | volume | 91 |
| Q43919733 | A combination of insulin and ubiquitin A20 promotes osteocalcin expression in adipose-derived stem cells |
| Q43507782 | A look at the interface between mesenchymal stromal cells and the immune system |
| Q33671117 | A novel technique to determine the cell type specific response within an in vitro co-culture model via multi-colour flow cytometry |
| Q58760232 | Alginate encapsulated multipotent adult progenitor cells promote corneal stromal cell activation via release of soluble factors |
| Q89699769 | Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study |
| Q92910500 | Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes |
| Q37565614 | BPA-toxicity via superoxide anion overload and a deficit in β-catenin signaling in human bone mesenchymal stem cells |
| Q36326923 | Biomaterial-mediated strategies targeting vascularization for bone repair |
| Q34664183 | Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment |
| Q27321912 | CD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum |
| Q41191186 | CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice. |
| Q50897287 | CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa. |
| Q61818608 | Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model |
| Q26822005 | Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells |
| Q90208140 | Comparison of The Therapeutic Effect of Syngeneic, Allogeneic, and Xenogeneic Adipose Tissue-Derived Mesenchymal Stem Cells on Abortion Rates in A Mouse Model |
| Q57072128 | Comparison of the biological characteristics of human mesenchymal stem cells derived from exfoliated deciduous teeth, bone marrow, gingival tissue, and umbilical cord |
| Q64277124 | Concise Review: Therapeutic Potential of the Mesenchymal Stem Cell Derived Secretome and Extracellular Vesicles for Radiation-Induced Lung Injury: Progress and Hypotheses |
| Q41141797 | Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells. |
| Q89951499 | Cxcr6-Based Mesenchymal Stem Cell Gene Therapy Potentiates Skin Regeneration in Murine Diabetic Wounds |
| Q34273076 | Different culture conditions modulate the immunological properties of adipose stem cells. |
| Q38981524 | Emerging role of mesenchymal stem cells during tuberculosis: The fifth element in cell mediated immunity |
| Q42320604 | Evaluating Wharton's Jelly-Derived Mesenchymal Stem Cell's Survival, Migration, and Expression of Wound Repair Markers under Conditions of Ischemia-Like Stress |
| Q26766574 | Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? |
| Q55285672 | Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis. |
| Q42214329 | Fibrin Scaffolds Designing in order to Human Adipose-derived Mesenchymal Stem Cells Differentiation to Chondrocytes in the Presence of TGF-β3 |
| Q36326838 | Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa |
| Q55411178 | Generation of hepatocyte- and endocrine pancreatic-like cells from human induced endodermal progenitor cells. |
| Q38628091 | Human Mesenchymal Stromal Cell Sheet Enhances Allograft Repair in a Mouse Model |
| Q96135902 | Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells |
| Q33872068 | Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model |
| Q100464339 | Improving the immunosuppressive potential of articular chondroprogenitors in a three-dimensional culture setting |
| Q51095214 | Influence of Mesenchymal Stem Cells Conditioned Media on Proliferation of Urinary Tract Cancer Cell Lines and Their Sensitivity to Ciprofloxacin. |
| Q47868876 | Inhibition of neuropathic hyperalgesia by intrathecal bone marrow stromal cells is associated with alteration of multiple soluble factors in cerebrospinal fluid. |
| Q50472681 | Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene. |
| Q43242462 | Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats |
| Q64985918 | Mechanisms of unprimed and dexamethasone-primed nonviral gene delivery to human mesenchymal stem cells. |
| Q59327153 | Mesenchymal Stem Cell Therapy for Aging Frailty |
| Q90310612 | Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease |
| Q92650424 | Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application |
| Q92622923 | Mesenchymal Stromal Cells Modulate Corneal Alloimmunity via Secretion of Hepatocyte Growth Factor |
| Q58855503 | Mesenchymal Stromal Cells: From Discovery to Manufacturing and Commercialization |
| Q50075766 | Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer. |
| Q85945994 | Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4(+)CD25 (+)FOXP3 (+) regulatory T-cells and inhibiting macrophage foam cell formation |
| Q38110707 | Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice. |
| Q38207602 | Mesenchymal stem cells in treating autism: Novel insights |
| Q24305096 | Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1/B7-H1 interactions |
| Q38725481 | Mesenchymal stromal cells in renal transplantation: opportunities and challenges. |
| Q47589580 | Molecular effect of human umbilical cord blood CD34-positive and CD34-negative stem cells and their conjugate in azoospermic mice |
| Q40173940 | Monitoring the ex-vivo expansion of human mesenchymal stem/stromal cells in xeno-free microcarrier-based reactor systems by MIR spectroscopy |
| Q38928462 | Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain. |
| Q40214885 | Multipotent adult progenitor cells improve the hematopoietic function in myelodysplasia. |
| Q42406826 | Multipotent adult progenitor cells on an allograft scaffold facilitate the bone repair process |
| Q36070752 | Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells |
| Q27316366 | Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs |
| Q36870064 | Olfactory ecto-mesenchymal stem cells possess immunoregulatory function and suppress autoimmune arthritis |
| Q41446638 | Osteogenic Potential of Multipotent Adult Progenitor Cells for Calvaria Bone Regeneration |
| Q39174525 | Osteogenic potential of stem cells-seeded bioactive nanocomposite scaffolds: A comparative study between human mesenchymal stem cells derived from bone, umbilical cord Wharton's jelly, and adipose tissue |
| Q37500590 | Partial Cranial Cruciate Ligament Tears Treated with Stem Cell and Platelet-Rich Plasma Combination Therapy in 36 Dogs: A Retrospective Study |
| Q39262680 | Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies. |
| Q38977281 | Pharmaceuticals and Stem Cells in Autism Spectrum Disorders: Wishful Thinking? |
| Q35806824 | Physical Activity Increases the Total Number of Bone-Marrow-Derived Mesenchymal Stem Cells, Enhances Their Osteogenic Potential, and Inhibits Their Adipogenic Properties |
| Q89105506 | Roles of Mesenchymal Stem Cells in Tissue Regeneration and Immunomodulation |
| Q38816893 | Secretome profiling of cytokines and growth factors reveals that neuro-glial differentiation is associated with the down-regulation of Chemokine Ligand 2 (MCP-1/CCL2) in amniotic fluid derived-mesenchymal progenitor cells. |
| Q40400293 | Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear Cells |
| Q27025609 | Stem Cells for Cutaneous Wound Healing |
| Q46681657 | Stem Cells in Spinal Fusion |
| Q38601272 | Stem cell therapy for cardiac regeneration: hits and misses. |
| Q58698694 | Stem cell therapy in autism: recent insights |
| Q40122051 | Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas |
| Q48107914 | Stem cells and cell-based therapies for cerebral palsy: A call for rigor |
| Q55313740 | The Effect of Antidepressants on Mesenchymal Stem Cell Differentiation. |
| Q64260095 | The Potential of Stem Cell Therapy to Repair White Matter Injury in Preterm Infants: Lessons Learned From Experimental Models |
| Q92528775 | The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis |
| Q26781292 | The immune response of stem cells in subretinal transplantation |
| Q42621315 | The issue of immunology in stem cell therapies: a pharmaceutical perspective |
| Q33577019 | The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis |
| Q28077974 | Therapeutic Strategies for Oxidative Stress-Related Cardiovascular Diseases: Removal of Excess Reactive Oxygen Species in Adult Stem Cells |
| Q60912266 | Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes |
| Q36269896 | Uncovering stem cell differentiation factors for salivary gland regeneration by quantitative analysis of differential proteomes |
| Q50064941 | Unravelling the biological secrets of microchimerism by single-cell analysis |
Search more.